Berry, Donald A.

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

Liu, M. C., Oxnard, G. R., Klein, E. A., Swanton, C., Seiden, M. V., Liu, M. C., Oxnard, G. R., Klein, E. A., Smith, D., Richards, D., et al. (2020) · Annals of Oncology

Cancer Genomics and DiagnosticsEpigenetics and DNA Methylation

Cited by 1,495

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

Chang, J. Y., Senan, S., Paul, M. A., Mehran, R. J., Louie, A. V., Balter, P., Groen, H. J. M., McRae, S. E., Widder, J., Feng, L., et al. (2015) · The Lancet Oncology

Lung Cancer Diagnosis and TreatmentAdvanced Radiotherapy Techniques

Cited by 1,462

Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation: A Randomized Controlled Trial

Wilber, D. J., Pappone, C., Neuzil, P., De Paola, A., Marchlinski, F., Natale, A., Macle, L., Daoud, E. G., Calkins, H., Hall, B., et al. (2010) · JAMA

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cited by 1,170

A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody

Swanson, C. J., Zhang, Y., Dhadda, S., Wang, J., Kaplow, J., Lai, R. Y. K., Lannfelt, L., Bradley, H., Rabe, M., Koyama, A., et al. (2021) · Alzheimer's Research & Therapy

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 847

Meta-analyses of colorectal cancer risk factors

Johnson, C. M., Wei, C., Ensor, J. E., Smolenski, D. J., Amos, C. I., Levin, B., & Berry, D. A. (2013) · Cancer Causes & Control

Colorectal Cancer Screening and DetectionCancer Risks and Factors

Cited by 779

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial

Nanda, R., Liu, M. C., Yau, C., Shatsky, R., Pusztai, L., Wallace, A., Chien, A. J., Forero-Torres, A., Ellis, E., Han, H., et al. (2020) · JAMA Oncology

Breast Cancer Treatment StudiesCancer Treatment and Pharmacology

Cited by 710

MDM2 Promotes Cell Motility and Invasiveness by Regulating E-Cadherin Degradation

Yang, J.-Y., Zong, C. S., Xia, W., Wei, Y., Ali-Seyed, M., Li, Z., Broglio, K., Berry, D. A., & Hung, M.-C. (2006) · Molecular and Cellular Biology

Ubiquitin and proteasome pathwaysCancer-related Molecular Pathways

Cited by 211

From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology

Raghav, K. P. S., Mahajan, S., Yao, J. C., Hobbs, B. P., Berry, D. A., Pentz, R. D., Tam, A., Hong, W. K., Ellis, L. M., Abbruzzese, J., et al. (2015) · Journal of Clinical Oncology

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 59

Charting a path toward combination therapy for Alzheimer’s disease

Stephenson, D., Perry, D., Bens, C., Bain, L. J., Berry, D., Krams, M., Sperling, R., Dilts, D., Luthman, J., Hanna, D., et al. (2015) · Expert Review of Neurotherapeutics

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 37

Precision Promise (PrP): an adaptive, multi-arm registration trial in metastatic pancreatic ductal adenocarcinoma (PDAC)

Picozzi, V. J., Duliege, A.-M., Collisson, E. A., Maitra, A., Hidalgo, M., Hendifar, A. E., Beatty, G. L., Doss, S., Matrisian, L. M., Herena, P. S., et al. (2022) · Journal of Clinical Oncology

Pancreatic and Hepatic Oncology ResearchStatistical Methods in Clinical Trials

Cited by 9